OMEGA MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OMEGA MED
Largest movements
- Cash -€15,966
down €15,966 (-68.0%), from €23,467 to €7,500
mainly Tax, wage and social debts (-€14,609) and Trade debts (-€2,094)
- Receivables within one year +€1,766
up €1,766 (+134%), from €1,321 to €3,087
of which Other amounts receivable: +€2,016
- Stocks and contracts -€1,500
down €1,500 (-6.4%), from €23,537 to €22,037
- Tax, wage and social debts -€14,609
down €14,609 (-51.5%), from €28,346 to €13,737
of which Remuneration and social security: -€16,170
- Trade debts -€2,094
down €2,094 (-93.8%), from €2,234 to €139
- Profit (loss) carried forward +€1,427
up €1,427 (+91.1%), from €1,566 to €2,993
- Turnover -€67,748
down €67,748 (-16.0%), from €423,984 to €356,237
- Purchases and services -€53,548
down €53,548 (-14.4%), from €373,122 to €319,574
- Staff costs -€33,270
down €33,270 (-51.8%), from €64,181 to €30,910
- Gross operating margin -€14,200
down €14,200 (-27.9%), from €50,863 to €36,662
- Financial charges -€6,174
down €6,174 (-97.6%), from €6,323 to €149
of which Non-recurring financial charges: -€6,147
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €48,325 | €32,625 | -€15,700 | -32.5% |
| Current assets | 29/58 | €48,325 | €32,625 | -€15,700 | -32.5% |
| Stocks and contracts in progress | 3 | €23,537 | €22,037 | -€1,500 | -6.4% |
| Stocks | 30/36 | €23,537 | €22,037 | -€1,500 | -6.4% |
| Amounts receivable within one year | 40/41 | €1,321 | €3,087 | +€1,766 | +134% |
| Trade receivables | 40 | €250 | - | -€250 | |
| Other amounts receivable | 41 | €1,071 | €3,087 | +€2,016 | +188% |
| Cash at bank and in hand | 54/58 | €23,467 | €7,500 | -€15,966 | -68.0% |
| Total equity and liabilities | 10/49 | €48,325 | €32,625 | -€15,700 | -32.5% |
| Equity | 10/15 | €17,066 | €18,493 | +€1,427 | +8.4% |
| Contributions | 10/11 | €15,500 | €15,500 | = | 0.0% |
| Contributions outside capital | 11 | €15,500 | €15,500 | = | 0.0% |
| Share premium | 1100/10 | €15,500 | €15,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,566 | €2,993 | +€1,427 | +91.1% |
| Amounts payable | 17/49 | €31,259 | €14,132 | -€17,127 | -54.8% |
| Amounts payable within one year | 42/48 | €31,259 | €14,132 | -€17,127 | -54.8% |
| Trade debts | 44 | €2,234 | €139 | -€2,094 | -93.8% |
| Suppliers | 440/4 | €2,234 | €139 | -€2,094 | -93.8% |
| Taxes, remuneration and social security | 45 | €28,346 | €13,737 | -€14,609 | -51.5% |
| Taxes | 450/3 | €3,297 | €4,858 | +€1,560 | +47.3% |
| Remuneration and social security | 454/9 | €25,049 | €8,879 | -€16,170 | -64.6% |
| Other amounts payable | 47/48 | €679 | €256 | -€423 | -62.3% |
| Turnover | 70 | €423,984 | €356,237 | -€67,748 | -16.0% |
| Goods, raw materials, services and sundry goods | 60/61 | €373,122 | €319,574 | -€53,548 | -14.4% |
| Remuneration, social security and pensions | 62 | €64,181 | €30,910 | -€33,270 | -51.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,000 | - | -€2,000 | |
| Other operating charges | 640/8 | €2,511 | €4,243 | +€1,731 | +68.9% |
| Gross operating margin | 9900 | €50,863 | €36,662 | -€14,200 | -27.9% |
| Operating profit (loss) | 9901 | -€17,830 | €1,509 | +€19,339 | |
| Financial income | 75/76B | €0 | €67 | +€67 | +30,500% |
| Recurring financial income | 75 | €0 | €67 | +€67 | +30,459% |
| Non-recurring financial income | 76B | €0 | €0 | -€0 | -59.1% |
| Financial charges | 65/66B | €6,323 | €149 | -€6,174 | -97.6% |
| Recurring financial charges | 65 | €175 | €149 | -€26 | -14.9% |
| Non-recurring financial charges | 66B | €6,148 | €0 | -€6,147 | -100.0% |
| Profit (loss) for the period before taxes | 9903 | -€24,152 | €1,427 | +€25,579 | |
| Profit (loss) for the period | 9904 | -€24,152 | €1,427 | +€25,579 | |
| Profit (loss) for the period to be appropriated | 9905 | -€24,152 | €1,427 | +€25,579 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.